Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):325-34. doi: 10.1161/ATVBAHA.111.241802. Epub 2011 Dec 8.

Abstract

Objective: We have previously found abrogated ischemia-induced coronary collateral growth in Zucker obese fatty (ZOF) rats compared with Zucker lean (ZLN) rats. Because ZOF rats have structural abnormalities in their mitochondria suggesting dysfunction and also show increased production of O(2), we hypothesized that mitochondrial dysfunction caused by oxidative stress impairs coronary collateral growth in ZOF.

Methods and results: Increased levels of reactive oxygen species were observed in aortic endothelium and smooth muscle cells in ZOF rats compared with ZLN rats. Reactive oxygen species levels were decreased by the mitochondria-targeted antioxidants MitoQuinone (MQ) and MitoTempol (MT) as assessed by MitoSox Red and dihydroethidine staining. Lipid peroxides (a marker of oxidized lipids) were increased in ZOF by ≈47% compared with ZLN rats. The elevation in oxidative stress was accompanied by increased antioxidant enzymes, except glutathione peroxidase-1, and by increased uncoupling protein-2 in ZOF versus ZLN rats. In addition, elevated respiration rates were also observed in the obese compared with lean rats. Administration of MQ significantly normalized the metabolic profiles and reduced lipid peroxides in ZOF rats to the same level observed in lean rats. The protective effect of MQ also suppressed the induction of uncoupling protein-2 in the obese rats. Resolution of mitochondrial oxidative stress by MQ or MT restored coronary collateral growth to the same magnitude observed in ZLN rats in response to repetitive ischemia.

Conclusions: We conclude that mitochondrial oxidative stress and dysfunction play a key role in disrupting coronary collateral growth in obesity and the metabolic syndrome, and elimination of the mitochondrial oxidative stress with MQ or MT rescues collateral growth.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Collateral Circulation / drug effects*
  • Collateral Circulation / physiology
  • Coronary Vessels / drug effects
  • Coronary Vessels / growth & development*
  • Disease Models, Animal
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Lipid Peroxides / metabolism
  • Male
  • Metabolic Syndrome / metabolism*
  • Metabolic Syndrome / physiopathology
  • Mitochondria, Heart / drug effects*
  • Mitochondria, Heart / physiology
  • Mitochondrial Proteins / metabolism
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Organophosphorus Compounds / pharmacology
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • Piperidines / pharmacology
  • Rats
  • Rats, Zucker
  • Reactive Oxygen Species / metabolism
  • Ubiquinone / pharmacology

Substances

  • Antioxidants
  • Lipid Peroxides
  • MitoTEMPO
  • Mitochondrial Proteins
  • Organophosphorus Compounds
  • Piperidines
  • Reactive Oxygen Species
  • Ubiquinone
  • mitoquinone